Article Abstract

Has moderate ischemic mitral regurgitation to be corrected?—Analysis of a randomized trial

Authors: Antonio Maria Calafiore, Sotiris Prapas, Walid Abukoudair, Michele Di Mauro


The correct treatment of ischemic mitral regurgitation (IMR) is still not well established. Even if the benefit of revascularization in patients with depressed LV function is well known, patients with a substantial amount of dysfunctional but viable myocardium may not improve EF or prognosis after revascularization alone. Lack of recovery in patients with a considerable amount of viable tissue may be related to increased LV volume due to ventricular remodeling. The onset of secondary MR is the main factor that may induce progressive LV dilatation, affecting survival and functional status.


  • There are currently no refbacks.

Article Options

Download Citation